Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07569120
In Vivo Noradrenergic System and AgingHospices Civils de LyonNot Yet RecruitingNot Applicable
NCT07569120Not Yet Recruiting
Not Applicable
In Vivo Noradrenergic System and AgingHospices Civils de Lyon
NCT07570134
Simulation-Based Interprofessional Education for Operating Room TeamsYonsei UniversityNot Yet RecruitingNot Applicable
NCT07570134Not Yet Recruiting
Not Applicable
Simulation-Based Interprofessional Education for Operating Room TeamsYonsei University
NCT07571824
A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy SubjectsCorium Innovations, Inc.RecruitingPhase 1
NCT07571824Recruiting
Phase 1
A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy...Corium Innovations, Inc.
NCT07570251
Evaluation of Cognitive Education Activities in Breast Cancer Patients Receiving ChemotherapySaglik Bilimleri UniversitesiCompletedNot Applicable
NCT07570251Completed
Not Applicable
Evaluation of Cognitive Education Activities in Breast Cancer Patients Receiving...Saglik Bilimleri Universi...
NCT07570589
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Centre Hospitalier Universitaire de NiceNot Yet Recruiting
NCT07570589Not Yet Recruiting
—
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evol...Centre Hospitalier Univer...
NCT07569887
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocognitive Disorders in Patients With Unruptured Arteriovenous Malformations Before and After Surgical TreatmentUniversity Hospital, MontpellierNot Yet RecruitingNot Applicable
NCT07569887Not Yet Recruiting
Not Applicable
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocogni...University Hospital, Mont...
NCT07571005
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaNovo Nordisk A/SNot Yet RecruitingPhase 3
NCT07571005Not Yet Recruiting
Phase 3
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps...Novo Nordisk A/S
NCT07569367
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia SpectrumBioSensicsNot Yet Recruiting
NCT07569367Not Yet Recruiting
—
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotem...BioSensics
NCT07571590
Effectiveness of a Self-Efficacy Based Educational Program on Glycemic Self-Monitoring, Diabetes Self-Management Knowledge, and Health-Related Quality of Life Among Adults With Type 2 Diabetes MellitusJerash Private UniversityNot Yet RecruitingNot Applicable
NCT07571590Not Yet Recruiting
Not Applicable
Effectiveness of a Self-Efficacy Based Educational Program on Glycemic Self-Moni...Jerash Private University
NCT07570914
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver MetastasesTianjin Medical University Cancer Institute and HospitalNot Yet RecruitingPhase 2
NCT07570914Not Yet Recruiting
Phase 2
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitab...Tianjin Medical Universit...
NCT07569094
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital of Guangzhou Medical UniversityNot Yet Recruiting
NCT07569094Not Yet Recruiting
—
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital...
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07570979
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate CancerNovartis PharmaceuticalsRecruitingPhase 1
NCT07570979Recruiting
Phase 1
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent o...Novartis Pharmaceuticals
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07571798
The Difference of Two and Three Fluoroscopic Views of Sacrum for Percutaneous Sacroiliac Screw Insertion in High Energy Posterior Pelvic Ring Injured PatientsChonburi hospitalActive Not RecruitingNot Applicable
NCT07571798Active Not Recruiting
Not Applicable
The Difference of Two and Three Fluoroscopic Views of Sacrum for Percutaneous Sa...Chonburi hospital
NCT07571902
Revised-Paravertebral Nerve Blocks for Enhanced Recovery After Stoma ClosureSixth Affiliated Hospital, Sun Yat-sen UniversityNot Yet RecruitingNot Applicable
NCT07571902Not Yet Recruiting
Not Applicable
Revised-Paravertebral Nerve Blocks for Enhanced Recovery After Stoma ClosureSixth Affiliated Hospital...
NCT07568704
Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA ImagesIntalight, IncRecruiting
NCT07568704Recruiting
—
Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA ImagesIntalight, Inc
NCT07569328
Low-dose Colchicine for CABG Graft Failure PreventionBeijing Anzhen HospitalNot Yet RecruitingNot Applicable
NCT07569328Not Yet Recruiting
Not Applicable
Low-dose Colchicine for CABG Graft Failure PreventionBeijing Anzhen Hospital
NCT07569068
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ AdenocarcinomaRuijin HospitalRecruitingPhase 2
NCT07569068Recruiting
Phase 2
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Posit...Ruijin Hospital
NCT07568756
Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer EvaluationBlue Earth DiagnosticsNot Yet RecruitingPhase 2
NCT07568756Not Yet Recruiting
Phase 2
Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Eval...Blue Earth Diagnostics
Result Breakdown
Not yet recruiting12 (60%)
Recruiting6 (30%)
Completed1 (5%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Not Specified4 (20%)
Phase 24 (20%)
Phase 12 (10%)
Phase 31 (5%)